Seeking Alpha

Quest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug...

Quest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug odanacatib, which may pay off to the tune of $75M. (earlier: success of odanacatib)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs